Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc

FDA held a public meeting on testing methods for asbestos in talc and cosmetic products containing talc on February 4, 2020 at the FDA White Oak Campus (10903 New Hampshire Ave, The Great Room, Building 31, Silver Spring, Md. 20993). The purpose of the public meeting was to discuss and obtain scientific data and information … Continue reading “Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc”

[...]

FDA bowed to industry for decades as alarms were sounded over talc

Since at least the 1970s, the regulatory agency downplayed health concerns about talc in powders and cosmetics, deferring again and again to manufacturers. Only now, as pressure mounts from lawsuits and a Reuters investigation, is the agency stepping up testing. At an invitation-only gathering late last year, U.S. regulators and their guests huddled at a … Continue reading “FDA bowed to industry for decades as alarms were sounded over talc”

[...]

Johnson & Johnson knew for decades that asbestos lurked in its Baby Powder

Facing thousands of lawsuits alleging that its talc caused cancer, J&J insists on the safety and purity of its iconic product. But internal documents examined by Reuters show that the company’s powder was sometimes tainted with carcinogenic asbestos and that J&J kept that information from regulators and the public. Darlene Coker knew she was dying. … Continue reading “Johnson & Johnson knew for decades that asbestos lurked in its Baby Powder”

[...]

FDA In Brief: FDA Releases Final Report of Talc-containing Cosmetic Products Tested for Asbestos

The following quote is attributed to Susan Mayne, Ph.D., director of the Center for Food Safety and Applied Nutrition: “The FDA is committed to keeping consumers safe from potentially contaminated cosmetic products. As part of this effort, in September 2018, the agency awarded AMA Analytical Services, Inc. (AMA) a one-year contract to test certain talc-containing … Continue reading “FDA In Brief: FDA Releases Final Report of Talc-containing Cosmetic Products Tested for Asbestos”

[...]

Zantac Recalls

Thanks to decades of regulatory oversight and pharmacovigilance, we tend to take for granted the quality and safety of our most used medicines. Sometimes, though, the challenges and complexities of ensuring this peace of mind are thrown into the spotlight. Recently, potentially carcinogenic nitrosamine impurities were found to be present in commercially available drug products. … Continue reading “Zantac Recalls”

[...]

Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-Nitrosodimethylamine (NDMA) Impurity

Jan 8, 2020 Audience: Consumer, Health Professional, Pharmacy January 8, 2020 — Denton Pharma, Inc. dba Northwind Pharmaceuticals, an affiliate of Northwind Pharmaceuticals, LLC (“Northwind”) today announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300mg, to the consumer level. The recall is in response to the manufacturer’s recall of all unexpired … Continue reading “Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-Nitrosodimethylamine (NDMA) Impurity”

[...]

Get The Support You Deserve

Speak With Us Now!

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

Concerned About Meeting in Person?

We offer video consultations
for your convenience.

954-289-6316